Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma

References

• Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030–44.
   PubMed Web of Science ®Google Scholar
• Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127(5 Suppl 1):S87–96.
   Google Scholar
• Schoniger-Hekele M, Muller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut 2001;48:103–9.
   PubMed Web of Science ®Google Scholar
• Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918–28.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Naguib NN, Nour-Eldin NE, Rao P, Emami AH, Zangos S, Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications. Eur J Radiol 2009;72(3):505–16.
   PubMed Web of Science ®Google Scholar
• Chaparro M, Gonzalez Moreno L, Trapero-Marugan M, Medina J, Moreno-Otero R. Review article: pharmacological therapy of hepatocellular carcinoma with sorafenib and other oral agents. Aliment Pharmacol Ther 2008;28(11-12):1269–77.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozetti F, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–9.
   PubMed Web of Science ®Google Scholar
• Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765–74.
   PubMed Web of Science ®Google Scholar
• Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91–6.
   PubMed Web of Science ®Google Scholar
• Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–70.
   PubMed Web of Science ®Google Scholar
• Jung GE, Encke J, Schmidt J, Rahmel A. Model for end-stage liver disease. New basis of allocation for liver transplantations. Chirurg 2008;79:157–63.
   PubMed Web of Science ®Google Scholar
• Freeman RB Jr. Is waiting time a measure of access to liver transplantation? Is shorter necessarily better? Hepatology 2007;46:602–3.
   PubMedGoogle Scholar
• Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983;148:397–401.
   PubMed Web of Science ®Google Scholar
• Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997;226:688–701; discussion 701–3.
   PubMed Web of Science ®Google Scholar
• Dharancy S, Boitard J, Decaens T, Sergent G, Boleslawski E, Duvoux C, Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl 2007;13:665–71.
   PubMedGoogle Scholar
• Georgiades CS, Hong K, Geschwind JF. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J 2008;14:117–22.
   PubMed Web of Science ®Google Scholar
• Timm S, Sotiropoulos GC, Draier M, Knüpffer J, Steger U, Lang H. Selective transarterial chemoembolization of advanced hepatocellular carcinomas: a reasonable palliative option. Transplant Proc 2008;40:3179–81.
   PubMed Web of Science ®Google Scholar
• Shin SW. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 2009;10:425–34.
   PubMed Web of Science ®Google Scholar
• Oldhafer KJ, Chavan A, Fruhauf NR, Flemming P, Schlitt HJ, Kubicka S, Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit? J Hepatol 1998;29:953–9.
   PubMed Web of Science ®Google Scholar
• Lesurtel M, Mullhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant 2006;6:2644–50.
   PubMed Web of Science ®Google Scholar
• Hoffmann K, Glimm H, Radeleff B, Richter G, Heining C, Schenkel I, Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]. BMC Cancer 2008;8:349.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421–30.
   PubMed Web of Science ®Google Scholar
• Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986;6:729–38.
   PubMed Web of Science ®Google Scholar
• Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646–9.
   PubMed Web of Science ®Google Scholar
• Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394–403.
   PubMed Web of Science ®Google Scholar
• Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009;10:35–43.
   PubMed Web of Science ®Google Scholar
• Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007;246:502–9; discussion 509–11.
   PubMed Web of Science ®Google Scholar
• Maleux G, van Malenstein H, Vandecaveye V, Heye S, Vaninbroukx J, Nevens F, Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions. Dig Dis 2009;27:157–63.
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, New guidelines to evaluate the response to treatment in solid tumors. European Organization for research and treatment of cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205–16.
   PubMed Web of Science ®Google Scholar
• Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 2007;30:6–25.
   PubMed Web of Science ®Google Scholar
• Heresbach D, Raoul JL, Bentue-Ferrer D, Bretagne JF, Van den Driessche J, Gastard J. Chemotherapy combined with Lipiodol. In vitro study of the kinetics of release of adriamycin. Gastroenterol Clin Biol 1989;13:775–8.
   PubMedGoogle Scholar
• Sakaguchi H, Uchida H, Nishimura Y, Guo QY, Yoshimura H, Ohishi H. Pharmacokinetic study of adriamycin in the emulsion mixed with lipiodol-difference resulting from composition and methods of preparation, and behavior after mesenteric arterial injection in rat. Gan To Kagaku Ryoho 1991;18:1349–55.
   PubMedGoogle Scholar
• Nakamura H, Hashimoto T, Oi H, Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 1989;170(3 Pt 1):783–6.
   PubMed Web of Science ®Google Scholar
• Sakamoto I, Aso N, Nagaoki K, Matsuoka Y, Uetani M, Ashizawa, Complications associated with transcatheter arterial embolization for hepatic tumors. Radiographics 1998;18:605–19.
   PubMed Web of Science ®Google Scholar
• Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol 2001;12:321–6.
   PubMed Web of Science ®Google Scholar
• Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheom J, Durand F, Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005;11:767–75.
   PubMed Web of Science ®Google Scholar
• Perez Saborido B, Meneu JC, Moreno E, García I, Moreno A, Fundora Y. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 2005;190:383–7.
   PubMed Web of Science ®Google Scholar
• Graziadei IW, Sandmueller H, Waldenberger P, Koenigsrainer A, Nachbaur K, Jaschke W, Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003;9:557–63.
   PubMed Web of Science ®Google Scholar
• Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007;13:272–9.
   PubMed Web of Science ®Google Scholar
• Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002;8:873–83.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998;27:1572–7.
   PubMed Web of Science ®Google Scholar
• Chua TC, Liauw W, Saxena A, Chu F, Glenn D, Chai A, Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Liver Int 2010;30:166–74.
   PubMed Web of Science ®Google Scholar
• Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329–38.
   PubMed Web of Science ®Google Scholar
• Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005;100:2708–16.
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005;11:1086–92.
   PubMed Web of Science ®Google Scholar
• Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007;46:474–81.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Cioni D, Pina CD, Crocetti L. Hepatocellular carcinoma: new options for image-guided ablation. J Hepatobiliary Pancreat Surg 2009; Epub ahead of print.
   Google Scholar
• Pérez Saborido B, Loinaz Segurola C, Gimeno Calvo A, Meneu Díaz JC, Abradelo de Usera M, Calvo Pulido J, Liver transplantation for hepatocellular carcinoma: our experience from 1986. Transplant Proc 2003;35:1825–6.
   PubMed Web of Science ®Google Scholar
• Herber S, Schneider J, Brecher B, Höhler T, Thelen M, Otto G, Pitton MB. TACE: therapy of the HCC before liver transplantation experiences. Rofo 2005;177:681–90.
   PubMedGoogle Scholar